Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis D Falo

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
Immunologic Research|March 6, 2007
Induction of T cell immunity by cutaneous genetic immunization with recombinant lentivectorYukai He, Louis D Falo
The Journal of Investigative Dermatology|January 26, 2020
Spherical Nucleic Acids as Emerging Topical Therapeutics: A Focus on PsoriasisEmrullah Korkmaz, Louis D Falo
Current Opinion in Molecular Therapeutics|October 13, 2007
Lentivirus as a potent and mechanistically distinct vector for genetic immunizationYukai He, Louis D Falo
Immunity|December 18, 2014
"Toll"-erance in the skinTina L Sumpter, Louis D Falo
Expert Review of Vaccines|April 2, 2008
Recombinant lentivector as a genetic immunization vehicle for antitumor immunityYukai He, David Munn, Louis D Falo
Journal of Immunology (Baltimore, Md. : 1950)|June 7, 2011
Knockdown of HMGB1 in tumor cells attenuates their ability to induce regulatory T cells and uncovers naturally acquired CD8 T cell-dependent antitumor immunityZuqiang Liu, Louis D Falo, Zhaoyang You
Journal for Immunotherapy of Cancer|January 7, 2021
Skin immunization for effective treatment of multifocal melanoma refractory to PD1 blockade and Braf inhibitorsXingxing Hao, Louis D Falo Iii, Guo Chen, et al.
Immunity|May 23, 2006
Skin-derived dendritic cells induce potent CD8(+) T cell immunity in recombinant lentivector-mediated genetic immunizationYukai He, Jiying Zhang, Cara Donahue, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2009
Tumor regulatory T cells potently abrogate antitumor immunityZuqiang Liu, Jin H Kim, Louis D Falo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 22, 2011
Genetic targeting of the active transcription factor XBP1s to dendritic cells potentiates vaccine-induced prophylactic and therapeutic antitumor immunityShenghe Tian, Zuqiang Liu, Cara Donahue, et al.
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Immunologic Research|March 6, 2007
Induction of T cell immunity by cutaneous genetic immunization with recombinant lentivectorYukai He, Louis D Falo
The Journal of Investigative Dermatology|January 26, 2020
Spherical Nucleic Acids as Emerging Topical Therapeutics: A Focus on PsoriasisEmrullah Korkmaz, Louis D Falo
Current Opinion in Molecular Therapeutics|October 13, 2007
Lentivirus as a potent and mechanistically distinct vector for genetic immunizationYukai He, Louis D Falo
Immunity|December 18, 2014
"Toll"-erance in the skinTina L Sumpter, Louis D Falo
Expert Review of Vaccines|April 2, 2008
Recombinant lentivector as a genetic immunization vehicle for antitumor immunityYukai He, David Munn, Louis D Falo
Journal of Immunology (Baltimore, Md. : 1950)|June 7, 2011
Knockdown of HMGB1 in tumor cells attenuates their ability to induce regulatory T cells and uncovers naturally acquired CD8 T cell-dependent antitumor immunityZuqiang Liu, Louis D Falo, Zhaoyang You
Journal for Immunotherapy of Cancer|January 7, 2021
Skin immunization for effective treatment of multifocal melanoma refractory to PD1 blockade and Braf inhibitorsXingxing Hao, Louis D Falo Iii, Guo Chen, et al.
Immunity|May 23, 2006
Skin-derived dendritic cells induce potent CD8(+) T cell immunity in recombinant lentivector-mediated genetic immunizationYukai He, Jiying Zhang, Cara Donahue, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2009
Tumor regulatory T cells potently abrogate antitumor immunityZuqiang Liu, Jin H Kim, Louis D Falo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 22, 2011
Genetic targeting of the active transcription factor XBP1s to dendritic cells potentiates vaccine-induced prophylactic and therapeutic antitumor immunityShenghe Tian, Zuqiang Liu, Cara Donahue, et al.
Pageof 8